Hironori Ishiguchi
Overview
Explore the profile of Hironori Ishiguchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishiguchi H, Yoshiga Y, Fukuda M, Fujii S, Hisaoka M, Hashimoto S, et al.
Open Heart
. 2025 Feb;
12(1).
PMID: 40021208
Background: Pre-procedural and post-procedural plasma B-type natriuretic peptide (BNP) levels can predict rhythm outcomes after catheter ablation for atrial fibrillation (AF). However, the significance of long-term events remains unclear. Therefore,...
2.
Huang B, Liu Y, Lam H, Ishiguchi H, Chao T, Huisman M, et al.
Eur J Clin Invest
. 2025 Jan;
55(3):e14378.
PMID: 39805630
Background: Coronary artery disease (CAD) and atrial fibrillation (AF) often coexist, but the impact of clinical phenotypes of CAD on outcomes in AF patients in the non-vitamin K antagonist oral...
3.
Bucci T, Romiti G, Ishiguchi H, Gerra L, Mantovani M, Huang B, et al.
EClinicalMedicine
. 2024 Dec;
78:102974.
PMID: 39687426
Background: Few data are available about the impact of oral anticoagulants (OAC) in patients with Atrial Fibrillation (AF) and clinical complexity (CC). Methods: We conducted a retrospective study utilising data...
4.
Liu Y, Chen Y, Olier I, Ortega-Martorell S, Huang B, Ishiguchi H, et al.
Eur J Clin Invest
. 2024 Dec;
55(3):e14371.
PMID: 39660499
Background: Although oral anticoagulation decreases the risk of thromboembolism in patients with atrial fibrillation (AF), a residual risk of thrombotic events still exists. This study aimed to construct machine learning...
5.
Ishiguchi H, Huang B, El-Bouri W, Dawson J, Lip G, Abdul-Rahim A
J Am Heart Assoc
. 2024 Nov;
13(23):e036799.
PMID: 39575723
Background: Cardiac complications may occur in patients following ischemic stroke (stroke-heart syndrome [SHS]). We investigated the mortality risk in patients with SHS and across the SHS manifestations. Methods And Results:...
6.
Ishiguchi H, Chen Y, Huang B, Gue Y, Correa E, Homma S, et al.
Eur J Clin Invest
. 2024 Nov;
55(3):e14360.
PMID: 39552607
Background: The prediction of ischaemic stroke in patients with heart failure with reduced ejection fraction (HFrEF) but without atrial fibrillation (AF) remains challenging. Our aim was to evaluate the performance...
7.
Li M, Huang B, Lam S, Ishiguchi H, Liu Y, Olshansky B, et al.
Eur J Clin Invest
. 2024 Nov;
55(2):e14347.
PMID: 39538376
Background: Anticoagulation therapy in patients with atrial fibrillation (AF) and concomitant cancer can be challenging due to the significantly increased risk of both embolism and bleeding. Moreover, the benefits and...
8.
Nakashima Y, Ishiguchi H, Miyazaki Y, Omuro A, Sano M
J Echocardiogr
. 2024 Nov;
PMID: 39485639
No abstract available.
9.
Ishiguchi H, Huang B, El-Bouri W, Dawson J, Lip G, Abdul-Rahim A
Eur Stroke J
. 2024 Oct;
:23969873241296391.
PMID: 39475369
Background: Adverse cardiac events following ischaemic stroke (stroke-heart syndrome, SHS) pose a clinical challenge. We investigated the association between initial blood pressure at stroke presentation and the risk of SHS....
10.
Ishiguchi H, Huang B, El-Bouri W, Lip G, Abdul-Rahim A
Eur Stroke J
. 2024 Oct;
:23969873241290440.
PMID: 39397359
Background: The patient clinical phenotypes at particularly high risk for early cardiac complications after a recent acute ischaemic stroke (AIS), that is, stroke-heart syndrome (SHS), remain poorly defined. We utilised...